Literature DB >> 8324867

Effect of vitamin A on methotrexate cytotoxicity in L1210 murine leukemia cells in culture.

J Yamamoto1, Y Nagai, T Horie, S Awazu.   

Abstract

Vitamin A (VA) protects the small intestine from methotrexate (MTX)-induced damage. However, before VA can be used as a remedy to protect cancer patients from MTX-induced damage to the intestine, it is essential to clarify whether or not it disturbs the antitumor activity of MTX. This study investigated the effect of VA on the antitumor activity of MTX in vitro in L1210 murine leukemia cells. The incorporation of [6-3H]-thymidine and [6-3H]-uridine, [5-3H]-uridine, and [4,5-3H]-leucine into DNA, RNA, and proteins, respectively, was examined to evaluate this effect. The incorporation of thymidine, the uridines, and leucine decreased dose-dependently in MTX-treated L1210 cells and profoundly in the MTX plus VA-treated L1210 cells, since VA itself had a cell-killing activity. Thus, MTX depressed the growth of L1210 cells dose-dependently and this depression was not affected by the presence of VA. The present study proved in L1210 murine leukemia cells in vitro that VA did not disturb the antitumor activity of MTX.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8324867     DOI: 10.1007/bf00686170

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  20 in total

Review 1.  THE BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ACTION AND EFFECTS OF THE FOLIC ACID ANTAGONISTS.

Authors:  W C WERKHEISER
Journal:  Cancer Res       Date:  1963-09       Impact factor: 12.701

2.  Change in small intestinal brush border membranes of rats following methotrexate administration.

Authors:  H Takeuchi; Y Kosakai; K Tsurui; K Hasegawa; T Horie; S Awazu
Journal:  Pharmacol Toxicol       Date:  1989-10

3.  Evidence for direct inhibition of de novo purine synthesis in human MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate.

Authors:  C J Allegra; K Hoang; G C Yeh; J C Drake; J Baram
Journal:  J Biol Chem       Date:  1987-10-05       Impact factor: 5.157

4.  Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.

Authors:  N Jaffe; E Frei; D Traggis; Y Bishop
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

5.  Studies on the mechanism of action of 5-aziridinyl-2, 4-dinitrobenzamide in tumor cells.

Authors:  H G Mandel; T A Connors; D H Melzack; K Merai
Journal:  Cancer Res       Date:  1974-02       Impact factor: 12.701

6.  Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed, and tumor cells in vitro.

Authors:  R Lotan; G L Nicolson
Journal:  J Natl Cancer Inst       Date:  1977-12       Impact factor: 13.506

Review 7.  Multiple functions of vitamin A.

Authors:  G Wolf
Journal:  Physiol Rev       Date:  1984-07       Impact factor: 37.312

8.  Vitamin A protects the small intestine from methotrexate-induced damage in rats.

Authors:  K Tsurui; Y Kosakai; T Horie; S Awazu
Journal:  J Pharmacol Exp Ther       Date:  1990-06       Impact factor: 4.030

9.  Protective effect of vitamin A against the methotrexate-induced damage to small intestine: a study on the crypt cells.

Authors:  Y Kosakai; T Horie; S Awazu
Journal:  Pharmacol Toxicol       Date:  1991-10

10.  Effects of mitomycin C, 5-fluorouracil and cyclophosphamide on drug absorption, enzyme activities and mucosal lipid composition of intestine.

Authors:  M Mizuno; M Tamura; M Hashida; H Sezaki
Journal:  J Pharmacobiodyn       Date:  1987-07
View more
  2 in total

1.  Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?

Authors:  Ayhan Dagdemir; Hasan Yildirim; Yuksel Aliyazicioglu; Yilmaz Kanber; Davut Albayrak; Sabri Acar
Journal:  Support Care Cancer       Date:  2004-02-06       Impact factor: 3.603

Review 2.  Systematic review of natural agents for the management of oral mucositis in cancer patients.

Authors:  Noam Yarom; Anura Ariyawardana; Allan Hovan; Andrei Barasch; Virginia Jarvis; Siri Beier Jensen; Yehuda Zadik; Sharon Elad; Joanne Bowen; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-06-14       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.